Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectoralis Minor Block in Hemiplegic Shoulder Pain
NCT06613646Completed
- Sponsor
- Istanbul University-Cerrahpaşa
- Start
- May 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine in hemiplegic shoulder pain (PHS) and Pectoralis Minor Syndrome (PMS), sponsored by Istanbul University-Cerrahpaşa. Primary endpoints: Pain Relief (Numeric Rating Scale) at 1 month and Passive Range of Motion of Shoulder at 1 month. Started May 2025; status: completed.
02
Drugs
lidocaine
03
Conditions
hemiplegic shoulder pain (PHS)Pectoralis Minor Syndrome (PMS)
Beyond the preview
Go deeper on NCT06613646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06613646.